首页> 外文期刊>Advances in Pharmacology and Pharmacy >Study on Prescribing Pattern of Antihypertensive Drugs in a Tertiary Care Hospital
【24h】

Study on Prescribing Pattern of Antihypertensive Drugs in a Tertiary Care Hospital

机译:三级医院抗高血压药处方模式研究

获取原文
       

摘要

Objective: To analyze prescription pattern of antihypertensive drugs in patients with hypertension alone and with coexisting diseases. Methodology: A descriptive cross- sectional study was conducted in outpatient department of tertiary care hospital in south India. A total of 286 prescriptions of patients diagnosed to have hypertension with or without coexisting diseases were collected. Details of prescriptions were entered in the preformed pro forma and analyzed. Result: The study included 138 (48.25%) male and 148 (51.75%) female. Out of 286 hypertensives, 122 (42.66%) patients were having co-existing type 2 diabetes mellitus (T2DM). And remaining 164 patients (57.34%) were only hypertensives. Out of 286 patients, 227 (79.31%) patients were on monotherapy, 49 (17.13%) were on dual therapy and remaining 10 patients were on triple anti-hypertensive drugs. Among 150 antihypertensive drugs that are prescribed for hypertensive patients withT2DM, 57 (38%) were calcium channel blocker (CCB), 40 (26.66%) were angiotensin converting enzyme inhibitors (ACEI), 31 (20.66%) were angiotensin receptor blockers (ARB), 13 (8.66%) were diuretics and remaining 9 (6%) were beta blockers. Similarly, among 206 antihypertensive drugs prescribed for hypertension alone patients, 97 (47%) were CCB, 37 (17.96%) were ACEI, 31 (15%) were ARB, 26 (12.62%) were diuretics and remaining 15 (7.28%) were beta blockers. Conclusion: The study has shown that majority of patients were on monotherapy (79.31%) and calcium channel blockers were commonly prescribed for hypertension in patients with or without type 2 diabetes mellitus followed by ACE inhibitors, ARB and beta blockers.
机译:目的:分析单纯高血压合并症患者的降压药处方。方法:在印度南部三级医院的门诊部进行了描述性横断面研究。总共收集了286份被诊断患有高血压,有或没有并存疾病的患者处方。处方的详细信息会输入到预先准备的备考文件中并进行分析。结果:该研究包括138名(48.25%)男性和148名(51.75%)女性。在286位高血压患者中,有122位(42.66%)患者并存2型糖尿病(T2DM)。其余164名患者(57.34%)仅属于高血压。在286例患者中,有227例(79.31%)接受单一疗法,有49例(17.13%)接受双重疗法,其余10例接受三联抗高血压药物治疗。在为T2DM高血压患者开出的150种降压药中,有57种(38%)是钙通道阻滞剂(CCB),有40种(26.66%)是血管紧张素转化酶抑制剂(ACEI),有31种(20.66%)是血管紧张素受体阻滞剂(ARB) ),其中13种(8.66%)是利尿剂,其余9种(6%)是β受体阻滞剂。同样,在206例仅用于高血压患者的降压药中,CCB 97例(47%),ACEI 37例(17.96%),ARB 31例(15%),利尿剂26例(12.62%),其余15例(7.28%)是β受体阻滞剂。结论:研究表明,大多数患者采用单一疗法(79.31%),对于有或没有2型糖尿病的患者,通常开具钙通道阻滞剂以治疗高血压,其次是ACE抑制剂,ARB和β阻滞剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号